Fig. 1
From: miR-129-5p as a biomarker for pathology and cognitive decline in Alzheimer’s disease
Schematic overview of the workflow of our analysis. AD Alzheimer’s dementia, MAP Memory and Aging Project, miRNAs microRNAs, mRNAs messenger RNAs, NCI no cognitive impairment, ROS Religious Orders Study, 3′-UTR 3′-untranslated region